New Cornell research published online Nov. 9 in Nature Cell Biology describes a system that controls levels of a cell's sensors, which are responsible for detecting the accumulation of misfolded proteins.
Cornell biomedical engineers have developed specialized white blood cells – dubbed "super natural killer cells" – that seek out cancer cells in lymph nodes with only one purpose: destroy them.
At the Cornell Entrepreneurship Summit in New York City Nov. 6, CEOs presented, students pitched business ideas, and President Garrett and spoke of Cornell's entrepreneurial roots.
A Weill Cornell Medicine investigators suggests a lung function test frequently to evaluate whether a smoker is at risk for developing pulmonary disease is likely mislabeling smokers as healthy.
Six Cornell researchers will receive grants totaling more than
$3 million as part of the National Science Foundation Secure and Trustworthy Cyberspace program.
Obesity impairs the body’s ability to use vitamin A appropriately and leads to deficiencies of the vitamin in major organs, according to new research conducted at Weill Cornell Medicine.
Weill Cornell Medicine finds a combination therapy lacking many debilitating effects manages mantle cell lymphoma, shrinking the malignancy and inducing remissions in most patients.
The Runway Startup Postdoc Program – described as "part business school, part research institution, part startup incubator" – is designed to advance the participants' research and launch new business ventures.
High levels of vitamin C kill certain kinds of colorectal cancers in cell cultures and mice, according to a new study from Weill Cornell Medicine investigators.